All data are based on the daily closing price as of October 30, 2025
t

Towa Pharmaceutical

4553.TSE
18.11 USD
-0.15
-0.82%

Overview

Last close
18.11 usd
Market cap
891.69M usd
52 week high
23.11 usd
52 week low
16.24 usd
Target price
25.5 usd

Valuation

P/E
7.2254
Forward P/E
16.7785
Price/Sales
0.5233
Price/Book Value
0.8351
Enterprise Value
2.14B usd
EV/Revenue
1.2681
EV/EBITDA
6.8502

Key financials

Revenue TTM
1.71B usd
Gross Profit TTM
618.28M usd
EBITDA TTM
282.21M usd
Earnings per Share
2.51 usd
Dividend
0.46 usd
Total assets
3.30B usd
Net debt
1.41B usd

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.
  • Symbol
    4553.TSE
  • Exchange
    TSE
  • Isin
    JP3623150004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Osaka
  • Web site
    https://www.towayakuhin.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top